Mylan and Upjohn now expect to complete their combination in the fourth quarter of this year, Pfizer Chief Executive Officer Albert Bourla said during a conference call. Mylan and Pfizer announced July 29, 2019 that they had agree to combine Mylan with Upjohn, Pfizer's off-patent branded and generic medicines business, to create